Diabetes treatment is constantly advancing, with new therapeutic options developing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the https://elijahonjt001239.livebloggs.com/45701110/novel-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment